Subjects and setting
Patients treated with TL from January 2020 to December 2020 were
prospectively recruited from our medical center. Patients benefited from
tracheoesophageal puncture and 1-month post-TL VP. The surgeon used the
Provox® 2 type prosthesis (Atos Medical AB, Hörby, Sweden). Patients
were followed by an experienced otolaryngologist and SLP for the voice
rehabilitation and the oncological follow-up. The first VP change was
performed by the senior SLP (GD) who was supervised by the senior head
and neck surgeon (SH). The rest of the VP changes were performed by the
same SLP without surgeon supervision; the surgeon being however called
in case of problems.